3 Critical Factors to Affect the Marijuana Industry in 2018

3 Critical Factors to Affect the Marijuana Industry in 2018

Here’s the skinny (skimmed from The Motley Fool): One: The highly anticipated legalization of recreational marijuana use in Canada this summer. Two: The FDA approves GW Pharmaceutical’s Epidiolex, a cannabis-based drug for childhood epilepsy. Three: Gallup poll...
Market Highs: GW Pharmaceuticals Breaks Out Pending FDA Review

Market Highs: GW Pharmaceuticals Breaks Out Pending FDA Review

Chart: Tradingview Last Tuesday, April 17, GW Pharmaceuticals (GWPH), known for its development of cannabis-derived medications, broke out of its downtrend in anticipation that its latest drug, Epidiolex—a treatment for childhood epilepsy—may favorably be reviewed and...